Mechanistically, studies have revealed that the JNK pathway, NOTCH pathway, RAS/MYC axis and Rb/E2F1 pathway participate in the development of H3.3K27M-positive gliomas [37,38,39,40]. The gene discussed is RB1; the disease is central nervous system cancer.